The Genomic Medicine Institute is committed to performing translational and clinical human genetics and genomics investigation and fostering innovation toward realizing the benefits of personalized genomic-based healthcare.
More About UsClick below to explore labs in our research areas of focus.
The Cheng lab develops and utilizes innovation network medicine methodologies and systems biology technologies to predict drug targets and identify mechanisms of human diseases.
Learn MoreThe Karaayvaz lab focuses on understanding early events in breast cancer with the goal of identifying individualized therapeutic vulnerabilities.
Learn MoreDr. Mata's lab studies the genes involved in neurological disorders, such as Parkinson's disease, with a significant focus on underrepresented populations. Dr. Mata also coordinates the Latin American Research Consortium on the Genetics of Parkinson’s disease.
Learn MoreAt Cleveland Clinic’s Center for Personalized Genetic Healthcare, treatment is centered around your unique genetic profile, and its impact on you and your family.
Lean MoreSharing genomic data for more than 100,000 colorectal cancer cases helps researchers discover 155 high-confidence genes linked to disease risk.
The open-source artificial intelligence (AI) technology uses human genetic data to identify candidate drugs.
Analyzing data from more than 5 million patients revealed telmisartan is associated with lower Alzheimer’s disease incidence in Black patients, providing clues for potential treatment and prevention.
Exciting investigation and groundbreaking discovery happens every day at Cleveland Clinic. Join our team of expert researchers at Genomic Medicine.
View Careers